Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: Comparative study with azole-susceptible Leishmania mexicana promastigotes

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2785-2791

  Rangel, Hector ^a   Dagger, Fracehuli ^a   Hernandez, Angel ^a   Liendo, Andreina ^b   Urbina, Julio A ^b  

^a FACULTAD DE CIENCIAS   (Venezuela)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; KETOCONAZOLE; TERBINAFINE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SENSITIVITY; LEISHMANIA BRAZILIENSIS; LEISHMANIA MEXICANA; LEISHMANIASIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0029844998     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2785     Document Type: Article

References (57)

1. Akuffo, H., M. Dietz, S. Teklemariam, T. Tadesse, G. Amare, and T. Yemane Berhan. 1990. The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica. Trans. R. Soc. Trop. Med. Hyg. 84:532-534.
2. Arthington, B. A., L. G. Rennet, P. L. Skatrud, C. J. Guynn, R. J. Barbuch, C. E. Ulbright, and M. Bard. 1991. Cloning, disruption and sequence of the gene encoding yeast C-5 sterol desaturase. Gene 102:39-44.
3. Ashman, W. H., R. J. Barbuch, C. E. Ulbright, H. W. Jarret, and M. Bard. 1991. Cloning and disruption of the yeast C-8 sterol isomerase gene. Lipids 26:628-632.
4. Bard, M., N. D. Lees, T. Turi, D. Craft, L. Cofrin, R. J. Barbuch, C. Koegel, and J. C. Loper. 1993. Sterol synthesis and viability of erg-11 (cytochrome P450 lanosterol demethylase) mutations in Saccharomyces cerevisiae and Candida albicans. Lipids 28:963-967.
5. Barrett-Bee, K., and N. S. Ryder. 1992. Biochemical aspects of ergosterol biosynthesis inhibition, p. 410-436. In J. Sutcliffe and N. H. Georgopapadakou (ed.), Emerging targets in antibacterial and antifungal chemotherapy. Chapman and Hall, New York.
6. Beach, D. H., L. J. Goad, and G. G. Holz, Jr. 1988. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes. Mol. Biochem. Parasitol. 31:149-162.
7. Berman, J. D., L. J. Goad, D. H. Beach, and G. G. Holz, Jr. 1986. Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine macrophage tumor cells. Mol. Biochem. Parasitol. 20:85-92.
8. Berman, J. D., G. G. Holz, Jr., and D. H. Beach. 1984. Effects of ketoconazole on growth and sterol biosynthesis by Leishmania mexicana mexicana promastigotes in culture. Mol. Biochem. Parasitol. 12:1-13.
9. Bloch, K. 1983. Sterol structure and membrane function. Crit. Rev. Biochem. 14:47-92.
10. Borelli, D. 1987. A clinical trial of itraconazole in the treatment of mycoses and leishmaniasis. Rev. Infect. Dis. 9(Suppl. 1):S57-S63.
11. Buttke, T. M., and K. Bloch. 1981. Utilization and metabolism of methyl-sterol derivatives in the yeast mutant strain GL7. Biochemistry 20:3267-3272.
12. Croft, S. L. 1988. Recent developments in the chemotherapy of leishmaniasis. Trends Pharmacol. Sci. 9:376-381.
13. Croft, S. L., J. A. Urbina, and R. Brun. 1997. Chemotherapy of human leishmaniasis and trypanosomiasis, p. 245-257. In G. Hide, J. C. Mottram, G. H. Commbs, and P. H. Holmes (ed.), Trypanosomiasis and leishmaniasis. CAB International, London.
14. Dahl, J. S., C. E. Dahl, and K. Bloch. 1980. Sterols in membranes: growth characteristics and membrane properties of Mycoplasma capricolum culture on cholesterol and lanosterol. Biochemistry 19:1472-1476.
15. Dan, M., E. Verner, J. El-On, F. Zuckerman, and D. Michaeli. 1986. Failure of oral ketoconazole to cure cutaneous ulcers caused by Leishmania braziliensis. Cutis 38:198-199.
16. Dedet, J. P., P. Jamet, P. Esterre, P. M. Ghipponi, C. Genin, and G. Lalande. 1986. Failure to cure Leishmania braziliensis guyanensis cutaneous leishmaniasis with oral ketoconazole. Trans. R. Soc. Trop. Med. Hyg. 80:296.
17. De Maio, A., and J. A. Urbina. 1984. Trypanosoma (Schizotrypanum) cruzi: terminal oxidases in two growth phases in vitro. Acta Cient. Venez. 35:136-141.
18. Ellenberger, T. E., and S. M. Beverley. 1989. Multiple drug resistance and conservative amplification of the H region of Leishmania major. J. Biol. Chem. 264:15094-15103.
19. Gaber, R. F., D. M. Copple, B. K. Kennedy, M. Vidal, and M. Bard. 1989. The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle sparking sterol. Mol. Cell. Biol. 9:3447-3456.
20. Goad, L. J., G. G. Holz, Jr., and D. H. Beach. 1984. Sterols of Leishmania species. Implications for biosynthesis. Mol. Biochem. Parasitol. 10:161-170.
21. Goad, L. J., G. G. Holz, Jr., and D. H. Beach. 1985. Sterols of ketoconazole-inhibited Leishmania mexicana mexicana promastigotes. Mol. Biochem. Parasitol. 15:257-279.
22. Hart, D. T., W. J. Lauwers, G. Willemsens, H. Vanden Bossche, and F. R. Opperdoes. 1989. Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages. Mol. Biochem. Parasitol. 33:123-134.
23. Haughan, P. A., M. L. Chance, and L. J. Goad. 1992. Effects of sinefungin on growth and sterol composition of Leishmania promastigotes. Biochem. Pharmacol. 77:147-154.
24. Haughan, P. A., M. L. Chance, and L. J. Goad. 1992. Synergism in vitro of lovastatin and miconazole as anti-leishmanial agents. Biochem. Pharmacol. 44:2199-2206.
25. Haughan, P. A., M. L. Chance, and L. J. Goad. 1995. Effects of an azasterol inhibitor of 24-transmethylation on sterol biosynthesis and growth of Leishmania donovani promastigotes. Biochem. J. 308:31-38.
26. Hernandez, A. G., A. Rascon, S. Kutner, H. Roman, and Z. Campos. 1993. Relationships between cell surface protease and acid phosphatase activities of Leishmania promastigote. Mol. Biol. Rep. 18:189-195.
27. Herwaldt, B., and J. D. Berman. 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46:296-306.
28. Huang, T.-H., A. J. DeSiervo, and Q.-X. Yang. 1991. Effect of cholesterol and lanosterol on the structure and dynamics of the cell membrane of Mycoplasma capricolum. Deuterium nuclear magnetic resonance study. Biophys. J. 59:691-702.
29. Jaffe, C. H. L., G. Grimaldi, and D. M. Pratt. 1984. The cultivation and cloning of Leishmania, p. 47-91. In C. M. Morel (ed.), Genes and antigens of parasites. 2nd ed. UNDP/World Bank/WHO, FINEP/CNPq/FIOCRUZ, Rio de Janiero, Brazil.
30. Jolliffe, D. S. 1986. Cutaneous leishmaniasis from Belize - treatment with ketoconazole. Clin. Exp. Dermatol. 11:62-68.
31. Larralde, G., J. Vivas, and J. A. Urbina. 1988. Concentration and time dependence of the effects of ketoconazole on growth and sterol biosynthesis in Trypanosoma (Schizotrypanum) cruzi epimastigotes. Acta Cient. Venez. 39:140-146.
32. Maldonado, R. A., J. Molina, G. Payares, and J. A. Urbina. 1993. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease. Antimicrob. Agents Chemother. 37: 1353-1359.
33. Navin, T. R., B. A. Arana, F. E. Arana, J. D. Berman, and J. F. Chajon. 1992. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J. Infect. Dis. 165:528-534.
34. Nes, W. D., G. G. Janssen, F. G. Crumley, M. Kalinowska, and T. Akihisa. 1993. The structural requirements of sterols for membrane function in Saccharomyces cerevisiae. Arch. Biochem. Biophys. 300:724-733.
35. Norton, S. A., S. Frankenburg, and S. N. Klaus. 1992. Cutaneous leishmaniasis acquired during military service in the Middle East. Arch. Dermatol. 128:83-87.
36. Olliaro, P. L., and A. D. M. Bryceson. 1993. Practical progress and new drugs for changing patterns of leishmaniasis, Parasitol. Today 9:323-328.
37. Parks, L. W., and W. M. Casey. 1995. Physiological implications of sterol biosynthesis in yeast. Annu. Rev. Microbiol. 49:95-116.
38. Parks, L. W., R. T. Lorenz, and W. M. Casey. 1992. Functions of sterols in yeast membranes, p. 393-409. In J. Sutcliffe and N. H. Georgopapadakou (ed.), Emerging targets in antibacterial and antifungal chemotherapy. Chapman and Hall, New York.
39. Ramirez, J. L., and P. Guevara. 1987. The ribosomal gene spacer as a tool for the taxonomy of Leishmania. Mol. Biochem. Parasitol. 22:177-183.
40. Ryder, N. S., and H. Mieth. 1992. Allylamine antifungal drugs. Curr. Top. Med. Mycol. 4:158-188.
41. Saenz, R. E., H. Paz, and J. D. Berman. 1990. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am. J. Med. 89:147-155.
42. Urbina, J. A., K. Lazardi, T. Aguirre, M. M. Piras, and R. Piras. 1988. Antiproliferative synergism of the allylamine SF-86327 and ketoconazole on epimastigotes and amastigotes of Trypansoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 32:1237-1242.
43. Urbina, J. A., K. Lazardi, T. Aguirre, M. M. Piras, and R. Piras. 1991. Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 35:730-735.
44. Urbina, J. A., K. Lazardi, E. Marchan, G. Visbal, T. Aguirre, M. M. Piras, K. Piras, R. A. Maldonado, G. Payares, and W. DeSouza. 1993. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vivo and in vitro studies. Antimicrob. Agents Chemother. 37:580-591.
45. Urbina, J. A., K. Lazardi, J. Vivas, G. Visbal, T. Aguirre, M. M. Piras, R. Piras, J. Molina, C. Sanoja, G. Payares, H. Rangel, F. Dager, A. Hernandez, and M. Angelis-Greaves. 1993. Recent advances in experimental chemotherapy of Chagas disease and leishmaniasis with the use of sterol biosynthesis inhibitors. Mem. Inst. Oswaldo Cruz Rio J. 88(Suppl. 1):85-87.
46. 31P nuclear magnetic resonance spectroscopy. Biochim. Biophys. Acta 1238:163-176.
47. 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Chemotherapy 42:294-307.
48. 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol. Biochem. Parasitol. 79:199-210.
49. Urcuyo, F. G., and N. Zaias. 1982. Oral ketoconazole in the treatment of leishmaniasis. Int. J. Dermatol. 21:414-416.
50. Vanden Bossche, H. 1990. Importance and role of sterols in fungal membranes, p. 135-157. In P. J. Kuhn, A. P. J. Trinci, M. J. Jung, M. W. Goosey, and L. G. Copping (ed.), Biochemistry of cell walls and membranes. Springer Verlag, Berlin.
51. Vanden Bossche, H. 1995. Chemotherapy of human fungal infections, p. 431-484. In H. Lyr (ed.), Modern selective fungicides. Properties, applications, mechanism of action. Gustav Fisher Verlag, Jena, Germany.
52. Vanden Bossche, H., and P. Marichal. 1992. Azole antifungals: mode of action, p. 25-40. In H. Yamaguchi, G. S. Kobayashi, and H. Takahashi (ed.), Recent progress in antifungal chemotherapy. Marcel Dekker, New York.
53. Vanden Bossche, H., P. Marichal, J. Gorrens, H. Geerts, and P. J. Janssen. 1988. Mode of action studies: basis for the search of new antifungal drugs. Ann. N. Y. Acad. Sci. 544:191-207.
54. Vannier-Santos, M. A., J. A. Urbina, A. Martiny, A. Neves, and W. DeSouza. 1995. Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania. J. Eukaryot. Microbiol. 42:337-346.
55. Weinrauch, L., R. Livishin, and J. El-On. 1987. Ketoconazole in cutaneous leishmaniasis. Br. J. Dermatol. 117:666-667.
56. Weinrauch, L., R. Livishin, Z. Evan-Paz, and J. El-On. 1983. Efficacy of ketoconazole in cutaneous leishmaniasis. Arch. Dermatol. Res. 275:353-354.
57. Yeagle, P. L. 1985. Lanosterol and cholesterol have different effects on phospholipid acyl chain ordering. Biochim. Biophys. Acta 815:33-36.